ΙΩΑΝΝΗΣ Γ. ΓΡΙΒΕΑΣ

MD,PhD

Ανακοινώσεις σε Διεθνή Συνέδρια

  • "USE OF ASCORBATE-RICH DIALYSATE IN HEMODIALYSIS PATIENTS"
    I. Griveas
    417 Army Share Fund Hospital, Athens, Greece
    57th ERA-EDTA Congress, Milan June 6-9, 2020
  • "PACLITAXEL-COATED BALLOON ANGIOPLASTY FOR STENOSIS OF ARTERIOVENOUS FISTULA IN PATIENTS UNDER HEMODIALYSIS: 18TH MONTH FOLLOW-UP"
    I. Griveas, G. Vourliotakis, I Kantounakis, et al.
    417 Army Share Fund Hospital, Athens, Greece
    57th ERA-EDTA Congress, Milan June 6-9, 2020
  • Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients after 10 months therapy
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    ASN-Renal week , Washington DC, 5-10 November 2019
  • Tumoral Calcinosis in hemodialysis patient
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    ASN-Renal week , Washington DC, 5-10 November 2019
  • The Importance of monitoring blood flow in the maintenance of vascular access in patients under hemodialysis
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    ASN-Renal week , Washington DC, 5-10 November 2019
  • EFFECT O CITRATE BASED DIALYSATE ON INTRADIALYTIC HEPARIN DOSEIN MAINTENANCE HEMODIALYSIS PATIENTS
    Ioannis Griveas
    PRIVATE RENAL CLINIC “ATHENS-NEPHROLOGY”
    56th ERA EDTA Congress, Budapest 13-16 June 2019
  • HYDRATION STATUS AND PHASE ANGLE ESTIMATION BY MULTIFREQUENCY BIOIMPEDANCE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Ioannis Griveas
    PRIVATE RENAL CLINIC “ATHENS-NEPHROLOGY”
    XIX International Congress on Nutrition and Metabolism in Renal Disease (ICRNM 2018) Genova, Italy - June 26/30, 2018
  • THE EFFICACY OF ASCORBATE-RICH DIALYSATE TO ATTENUATE ANAEMIA IN MAINTENANCE HEMODIALYSIS PATIENTS
    Ioannis Griveas
    PRIVATE DIALYSIS UNIT “NEFROIATRIKI”, ATHENS, Greece - NEPHROLOGY, 417 VETERANS ARMY ADMINISTRATION HOSPITAL OF ATHENS, ATHENS, Greece. - Group/Team: Private Dialysis Unit "NEFROIATRIKI".
    55th ERA-EDTA, Copenhagen 24-27 May 2018. and XIX International Congress on Nutrition and Metabolism in Renal Disease (ICRNM 2018) Genova, Italy - June 26/30, 2018
  • SUCROFERRIC OXYHYDROXIDE: A NOVEL PHOSPHATE BINDER FOR THE MANAGEMENT OF MINERAL BONE DISEASE IN DIALYSIS PATIENTS WITH "PLEIOTROPIC" EFFECTS
    I.Griveas, C. Andriopoulos, P. Sitaras, M. Aktsiali.
    PRIVATE DIALYSIS UNIT “NEFROIATRIKI”, ATHENS, Greece - NEPHROLOGY, 417 VETERANS ARMY ADMINISTRATION HOSPITAL OF ATHENS, ATHENS, Greece. - Group/Team: Private Dialysis Unit "NEFROIATRIKI".
    55th ERA-EDTA, Copenhagen 24-27 May 2018.
  • Sucroferric Oxyhydroxide: A Novel Phosphate Binder Only or Something More?
    Ioannis Griveas
    PRIVATE DIALYSIS UNIT “NEFROIATRIKI”, ATHENS, Greece - NEPHROLOGY, 417 VETERANS ARMY ADMINISTRATION HOSPITAL OF ATHENS, ATHENS, Greece. - Group/Team: Private Dialysis Unit "NEFROIATRIKI".
    ASN-Renal week , N. Orleans 31 October-20 November 2017
  • Impact of Oral Sucrosomial Iron in Anemia of CKD Patients and Its Relation with Mineral Bone Disease Parameters
    Ioannis Griveas.1,2 1401
    General Military Hospital of Athens, Athens, Greece; RENAL CLINIC “ATHENS-NEPHROLOGY”, ATHENS, Greece.
    ASN-Renal week , N. Orleans 31 October-20 November 2017
  • HCV Viraemia in Anti-HCV-Negative Haemodialysis Patients: A Myth?
    Ioannis Griveas.1,2
    1401 General Military Hospital of Athens, Athens, Greece;
    2PRIVATE DIALYSIS UNIT “NEFROIATRIKI”, ATHENS, Greece.
    ASN-Renal week , N. Orleans 31 October-20 November 2017
  • Efficacy And Safety Of Sucroferric Oxyhydroxide In Haemodialysis Patients With Mineral Bone Disease
    Authors: Ioannis Griveas1,2, Panagiotis Sitaras2, Christos Andriopoulos3, Maro Aktsiali4, 1417 NIMTS, Nephrology Department, Chalandri, Athens, GREECE, 2Private Dialysis Unit, Dialysis Unit, Metamorphosi, Athens, GREECE, 3Private Dialysis Unit "Nefroiatriki", Nephrology, Metamorphosi, Athens, GREECE, 4Private Dialysis Unit "Nefroiatriki", Dialysis Unit, Metamorphosi, Athens, GREECE.
    Session Info: Poster Session: Dialysis - Bone disease, I.Griveas, C. Andriopoulos, P. Sitaras, M. Aktsiali.
    1PRIVATE DIALYSIS UNIT “NEFROIATRIKI”, ATHENS, Greece; 2NEPHROLOGY, 417 VETERANS ARMY ADMINISTRATION HOSPITAL OF ATHENS, ATHENS, Greece.
    2RENAL CLINIC “ATHENS-NEPHROLOGY”, ATHENS, Greece. Group/Team: Private Dialysis Unit "NEFROIATRIKI".
    54th ERA-EDTA, Madrid 3-6 Iουνίου 2017.
  • Abdominal Aortic Calicifications as a Prognostic Factor of All CauseMortality in Hemodialysis Patients
    Kyriaki Stamatelou,1 Dimitra Bacharaki,2 Ioannis Griveas,3 John Kyriazis,4 Dimitrios V. Vlahakos.2 .
    1Nephrology, Galinos Hospital, Athens, Greece;
    2Nephrology, Atticon Hospital, Chaidari, Greece;
    3Dialysis, NEFROIATRIKI, Athens, Greece; 4Nephrology, General Hospital, Chios, Greece.
    ASN-Renal week , Chicago 15-20 November 2016.
  • Εffect of citrate based on anticoagulation therapy in maintenance haemodialysis patients
    I. Griveas.
    53rd ERA-EDTA, Vienna 21-24 May 2016.